90 related articles for article (PubMed ID: 17705265)
1. Hepatitis C treatment, subcutaneous naltrexone implants, and methadone maintenance treatment.
Novick DM; Kreek MJ
Hepatology; 2007 Sep; 46(3):951-2. PubMed ID: 17705265
[No Abstract] [Full Text] [Related]
2. Comparing drug-related hospital morbidity following heroin dependence treatment with methadone maintenance or naltrexone implantation.
Ngo HT; Tait RJ; Hulse GK
Arch Gen Psychiatry; 2008 Apr; 65(4):457-65. PubMed ID: 18391134
[TBL] [Abstract][Full Text] [Related]
3. [Documented effect of methadone, but not naltrexone].
Heilig M
Lakartidningen; 2002 Feb; 99(6):551-2. PubMed ID: 11881232
[No Abstract] [Full Text] [Related]
4. Mortality in heroin users 3 years after naltrexone implant or methadone maintenance treatment.
Tait RJ; Ngo HT; Hulse GK
J Subst Abuse Treat; 2008 Sep; 35(2):116-24. PubMed ID: 17931824
[TBL] [Abstract][Full Text] [Related]
5. [Methadone and naltrexone in heroin addiction--an explanation from the SBU].
Asplund K; Jonsson E
Lakartidningen; 2002 Feb; 99(6):552-3. PubMed ID: 11881233
[No Abstract] [Full Text] [Related]
6. Naltrexone treatment of combined alcohol and opioid dependence: deterioration of co-morbid major depression.
Schürks M; Overlack M; Bonnet U
Pharmacopsychiatry; 2005 Mar; 38(2):100-2. PubMed ID: 15744636
[TBL] [Abstract][Full Text] [Related]
7. Methadone maintenance treatment of heroin addiction.
Davis EP
Del Med J; 1971 Sep; 43(9):248-51. PubMed ID: 5097505
[No Abstract] [Full Text] [Related]
8. Benefits of retention in methadone maintenance and chronic medical conditions as risk factors for premature death among older heroin addicts.
Fareed A; Casarella J; Amar R; Vayalapalli S; Drexler K
J Psychiatr Pract; 2009 May; 15(3):227-34. PubMed ID: 19461397
[TBL] [Abstract][Full Text] [Related]
9. Hepatitis C infection and lymphomas: is there any benefit in viral treatment?
Bruni L; De Sanjose S
Gastroenterology; 2006 Aug; 131(2):685-6; author reply 686-7. PubMed ID: 16890632
[No Abstract] [Full Text] [Related]
10. Methadone and the private practitioner.
J Med Soc N J; 1971 Jan; 68(1):70-1. PubMed ID: 5275484
[No Abstract] [Full Text] [Related]
11. Pharmacotherapy of hepatitis C virus infection: a brief review.
Quan DJ
Nephrol Nurs J; 2009; 36(3):333-7. PubMed ID: 19588704
[TBL] [Abstract][Full Text] [Related]
12. [Interactions with methadone and buprenorphine].
Bakke E; Bachs L
Tidsskr Nor Laegeforen; 2009 Nov; 129(22):2364-6. PubMed ID: 19935937
[TBL] [Abstract][Full Text] [Related]
13. Widening the door: the evolution of hepatitis C treatment in patients with psychiatric disorders.
Geppert CM; Arora S
Hepatology; 2007 Oct; 46(4):957-9. PubMed ID: 17886300
[No Abstract] [Full Text] [Related]
14. Methadone, a new look at an old drug.
Treuting JJ
Med Leg Bull; 1971 Aug; 20(8):1-12. PubMed ID: 5564449
[No Abstract] [Full Text] [Related]
15. Methadone in the management of opiate addiction.
Med Lett Drugs Ther; 1969 Nov; 11(24):97-9. PubMed ID: 5356042
[No Abstract] [Full Text] [Related]
16. Slow-release oral morphine for maintenance treatment of opioid addicts intolerant to methadone or with inadequate withdrawal suppression.
Kastelic A; Dubajic G; Strbad E
Addiction; 2008 Nov; 103(11):1837-46. PubMed ID: 19032534
[TBL] [Abstract][Full Text] [Related]
17. Psychobiological responses to drug cues before and after methadone intake in heroin-dependent patients: a pilot study.
Walter M; Wiesbeck GA; Bloch N; Aeschbach S; Olbrich HM; Seifritz E; Dürsteler-MacFarland KM
Eur Neuropsychopharmacol; 2008 May; 18(5):390-3. PubMed ID: 18299189
[TBL] [Abstract][Full Text] [Related]
18. Association of dopamine and opioid receptor genetic polymorphisms with response to methadone maintenance treatment.
Crettol S; Besson J; Croquette-Krokar M; Hämmig R; Gothuey I; Monnat M; Déglon JJ; Preisig M; Eap CB
Prog Neuropsychopharmacol Biol Psychiatry; 2008 Oct; 32(7):1722-7. PubMed ID: 18687376
[TBL] [Abstract][Full Text] [Related]
19. Drug abuse in heroin users. An experimental study of self-administration of methadone, codeine, and pentazocine.
Schuster CR; Smith BB; Jaffe JH
Arch Gen Psychiatry; 1971 Apr; 24(4):359-62. PubMed ID: 4927981
[No Abstract] [Full Text] [Related]
20. Development of novel agents for the treatment of hepatitis C virus.
Swan T; Chung RT
Hepatology; 2008 Apr; 47(4):1426. PubMed ID: 18322936
[No Abstract] [Full Text] [Related]
[Next] [New Search]
